AVIE - ETF AI Analysis
Top Page
Avantis Inflation Focused Equity ETF (AVIE)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, showing solid momentum.
Inflation-Resilient Sector Mix
Heavy exposure to health care, energy, and consumer defensive companies can help the fund hold up better when inflation is elevated.
Solid Top Holdings Performance
Most of the largest positions, especially in energy and health care, have shown strong or steady performance, supporting the fund’s returns.
Negative Factors
High U.S. Concentration
The portfolio is almost entirely invested in U.S. companies, offering very limited diversification across global markets.
Sector Concentration Risk
Large weights in just a few sectors like health care and energy mean the fund could be hit hard if those areas fall out of favor.
Underperforming Key Holding
One of the largest positions, Berkshire Hathaway, has shown weak performance this year, which can drag on overall returns.
AVIE vs. SPDR S&P 500 ETF (SPY)
AUM12.87M
RegionNorth America
Expense Ratio0.25%
Beta0.39
IssuerAvantis
Inception DateSep 27, 2022
Dividend Yield1.45%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,757
30 Day Avg. Volume1,839
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
90.49Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering359
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AVIE Summary
The Avantis Inflation Focused Equity ETF (AVIE) is a stock fund that aims to help investors deal with rising prices by focusing on companies that may hold up well during inflation. It doesn’t track a traditional index, but follows a total market theme with a tilt toward sectors like health care, energy, and consumer staples. Well-known holdings include Berkshire Hathaway and Exxon Mobil. Investors might consider AVIE for broad diversification while trying to protect their money’s buying power. A key risk is that it is still a stock fund, so its value can go up and down with the overall market and inflation trends.
How much will it cost me?The Avantis Inflation Focused Equity ETF (AVIE) has an expense ratio of 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed ETFs because it focuses on inflation-conscious equity investments while maintaining broad market exposure.
What would affect this ETF?The Avantis Inflation Focused Equity ETF (AVIE) could benefit from rising inflation, as its focus on companies with strong pricing power and fundamentals may help it perform well in such environments. Positive trends in sectors like Health Care and Energy, which make up a significant portion of its holdings, could also drive growth. However, economic slowdowns or regulatory changes affecting key sectors like Energy or Financials, as well as declining inflation concerns, could negatively impact its performance.
AVIE Top 10 Holdings
AVIE leans heavily into U.S. health care and energy, and that’s where the story starts. Exxon and Chevron have been rising steadily, giving the fund a strong tailwind from the energy patch. On the health care side, Johnson & Johnson and AbbVie are pulling their weight, while Eli Lilly’s more mixed recent run has taken a bit of shine off the sector. Consumer staples like Procter & Gamble add a steady, defensive backbone, and Berkshire Hathaway sits in the middle as a quiet anchor rather than a big performance driver.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Berkshire Hathaway B | 5.23% | $664.37K | $992.98B | 5.42% | 66 Neutral | |
| Exxon Mobil | 5.14% | $652.77K | $694.67B | 52.57% | 74 Outperform | |
| Procter & Gamble | 3.57% | $453.13K | $351.26B | 1.03% | 69 Neutral | |
| Eli Lilly & Co | 3.48% | $442.11K | $1.11T | 41.48% | 72 Outperform | |
| Chevron | 3.07% | $389.89K | $418.82B | 42.36% | 71 Outperform | |
| UnitedHealth | 2.49% | $316.79K | $340.46B | 7.00% | 72 Outperform | |
| Philip Morris | 2.46% | $311.98K | $313.58B | 25.38% | 61 Neutral | |
| Johnson & Johnson | 2.32% | $294.18K | $630.04B | 37.08% | 78 Outperform | |
| Coca-Cola | 2.23% | $283.67K | $378.84B | 31.34% | 75 Outperform | |
| AbbVie | 1.99% | $253.35K | $488.55B | 19.94% | 66 Neutral |
AVIE Technical Analysis
Positive
―
Price Trends
79.44
Positive
77.16
Positive
74.06
Positive
Market Momentum
0.12
Negative
65.17
Neutral
97.15
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 78.81, equal to the 50-day MA of 79.44, and equal to the 200-day MA of 74.06, indicating a bullish trend. The MACD of 0.12 indicates Negative momentum. The RSI at 65.17 is Neutral, neither overbought nor oversold. The STOCH value of 97.15 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVIE.
AVIE Peer Comparison
Comparison Results
Performance Comparison
AVIE
Avantis Inflation Focused Equity ETF
80.62
18.61
30.01%
BAMD
Brookstone Dividend Stock ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
PFOE
Pathfinder Focused Opportunities ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
VAMO
Cambria Value & Momentum ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents